Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Vivos Therapeutics Community
NasdaqCM:VVOS Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Vivos Therapeutics
Popular
Undervalued
Overvalued
Community Investing Ideas
Vivos Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
FDA Clearance And Middle East Expansion Will Secure Future Success
Key Takeaways Strategic alliances and clinic acquisitions aim to increase patient conversions, boosting revenue and margins through higher treatment uptake. Successful Middle East expansion and FDA clearance for severe OSA treatment enhance clinical credibility, driving significant international sales and revenue growth.
View narrative
US$5.85
FV
55.0% undervalued
intrinsic discount
17.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
VVOS
VVOS
Vivos Therapeutics
Your Fair Value
US$
Current Price
US$2.63
62.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-24m
32m
2015
2018
2021
2024
2025
2027
2030
Revenue US$32.4m
Earnings US$2.4m
Advanced
Set Fair Value